Showing 1,921 - 1,940 results of 2,988 for search '"Mutation"', query time: 0.07s Refine Results
  1. 1921

    Vitesse, réseau, vision : La malle poste-anglaise de Thomas de Quincey by Jean-Christophe Valtat

    Published 2015-06-01
    “…Usually linked to Opium, the visionary romantic aesthetic of Thomas De Quincey, can also be refered to the technological mutations of the emerging industrial modernity. The English Mail-Coach, especially, can be regarded as seminal text about the memorial and cognitive effects of such mutations. …”
    Get full text
    Article
  2. 1922

    A Cell Model for Conditional Profiling of Androgen-Receptor-Interacting Proteins by K. A. Mooslehner, J. D. Davies, I. A. Hughes

    Published 2012-01-01
    “…Partial androgen insensitivity syndrome (PAIS) is associated with impaired male genital development and can be transmitted through mutations in the androgen receptor (AR). The aim of this study is to develop a cell model suitable for studying the impact AR mutations might have on AR interacting proteins. …”
    Get full text
    Article
  3. 1923

    ARMC5 Primary Bilateral Macronodular Adrenal Hyperplasia Associated with a Meningioma: A Family Report by M. J. Ferreira, J. Pedro, D. Salazar, C. Costa, J. Aragão Rodrigues, M. M. Costa, A. Grangeia, J. L. Castedo, D. Carvalho

    Published 2020-01-01
    “…Familial clustering suggests a genetic cause that has been confirmed with the identification of some genetic mutations, including inactivating germline mutations, in armadillo repeat containing 5 (ARMC5) gene. …”
    Get full text
    Article
  4. 1924

    The discovery and characterization of K‐563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp by Ran Hori, Kozo Yamaguchi, Hidetaka Sato, Miwa Watanabe, Kyoko Tsutsumi, Susumu Iwamoto, Masayuki Abe, Hideyuki Onodera, Satoshi Nakamura, Ryuichiro Nakai

    Published 2019-03-01
    “…Previous reports found that aberrant Keap1/Nrf2 pathway activation due to Kelch‐like ECH‐associated protein 1 (Keap1) mutations or Nuclear factor E2‐related factor 2 (Nrf2) mutations induced resistance of cancer cells to chemotherapy and accelerated cell growth via the supply of nutrients. …”
    Get full text
    Article
  5. 1925
  6. 1926

    Distal protein-protein interactions contribute to nirmatrelvir resistance by Eric M. Lewandowski, Xiujun Zhang, Haozhou Tan, Aiden Jaskolka-Brown, Navita Kohaal, Aliaksandra Frazier, Jesper J. Madsen, Lian M. C. Jacobs, Jun Wang, Yu Chen

    Published 2025-02-01
    “…Resistance mutants identified clinically and in viral passage assays contain a combination of active site mutations (e.g., E166V, E166A, L167F), which reduce inhibitor binding and enzymatic activity, and non-active site mutations (e.g., P252L, T21I, L50F), which restore the fitness of viral replication. …”
    Get full text
    Article
  7. 1927

    Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies by Wen-Ting K. Tsai, Yinyin Li, Zhaojun Yin, Peter Tran, Qui Phung, Zhenru Zhou, Kun Peng, Dan Qin, Sien Tam, Christoph Spiess, Jochen Brumm, Manda Wong, Zhengmao Ye, Patrick Wu, Sivan Cohen, Paul J. Carter

    Published 2024-12-01
    “…For example, we have extensively used knobs-into-holes (KIH) mutations to facilitate the heterodimerization of antibody heavy chains and more recently Fab mutations to promote cognate heavy/light chain pairing for efficient in vivo assembly of bispecific IgG in single host cells. …”
    Get full text
    Article
  8. 1928

    Se nourrir à Hanoi : les recompositions du système alimentaire d’une ville émergente by Gwenn Pulliat

    Published 2012-10-01
    “…The example of food shows how mutations of Hanoi deepen social inequalities.…”
    Get full text
    Article
  9. 1929
  10. 1930

    Prenatal Counseling and Diagnosis of COX20 Gene-Related Mitochondrial Complex IV Deficiency: A Case Report and Literature Review by Su J, Zeng L, Chen H, Tong J, Chen Y, Huang L, Deng L, Huang Y

    Published 2025-01-01
    “…Through the application of whole-exome sequencing (WES), compound heterozygous COX20 mutations (c.41A>G and c.259C>T) were detected, leading to the confirmation of a diagnosis of mitochondrial complex IV deficiency. …”
    Get full text
    Article
  11. 1931

    MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis by Vishesh Khanna, Gohar Eslami, Rochelle Reyes, Robert Diep, Sebastian Fernandez-Pol, Henning Stehr, Carlos Jose Suarez, Harlan Pinto, James M. Ford, Tian Yi Zhang, Christopher T. Chen

    Published 2025-02-01
    “…Plasma TP53 mutations were similarly detected among 4 other patients treated at our institution, with the number of mutations correlating strongly with duration of treatment. …”
    Get full text
    Article
  12. 1932

    Cognitive Impairment in Genetic Parkinson’s Disease by A. Planas-Ballvé, D. Vilas

    Published 2021-01-01
    “…In this review, we summarize data regarding cognitive function on clinical studies, neuroimaging, and biological markers of cognitive decline in autosomal dominant PD linked to mutations in LRRK2 and SNCA, autosomal recessive PD linked to Parkin and PINK1, and also PD linked to GBA mutations.…”
    Get full text
    Article
  13. 1933

    Molecular Analyses of Aspirated Cystic Fluid for the Differential Diagnosis of Cystic Lesions of the Pancreas: A Systematic Review and Meta-Analysis by Xiaorong Guo, Xianbao Zhan, Zhaoshen Li

    Published 2016-01-01
    “…Conclusion. Tests of KRAS mutations could confirm but not exclude a diagnosis of a mucinous or malignant pancreatic cyst.…”
    Get full text
    Article
  14. 1934

    A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges by Erica di Martino, Darren C. Tomlinson, Margaret A. Knowles

    Published 2012-01-01
    “…FGFR1 is not mutated in UC, but overexpression is frequent in all grades and stages and recent data indicate a role in urothelial epithelial-mesenchymal transition. …”
    Get full text
    Article
  15. 1935

    Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy by Peter Gee, Huaigeng Xu, Akitsu Hotta

    Published 2017-01-01
    “…In particular, Duchenne muscular dystrophy (DMD) has been an exemplary monogenic disease model for combining these technologies to demonstrate that genome editing can correct genetic mutations in DMD patient-derived iPSCs. DMD is an X-linked genetic disorder caused by mutations that disrupt the open reading frame of the dystrophin gene, which plays a critical role in stabilizing muscle cells during contraction and relaxation. …”
    Get full text
    Article
  16. 1936
  17. 1937
  18. 1938

    Analysis of marker substitutions in A/chicken/Astrakhan/2171-1/2020 H5N8 isolate of avian influenza virus recovered in the Astrakhan Oblast by N. G. Zinyakov, A. V. Andriyasov, Ye. V. Ovchinnikova, A. A. Kozlov, P. D. Zhestkov, D. B. Andreychuk, I. A. Chvala

    Published 2021-07-01
    “…No mutations affecting virus sensitivity to anti-viral medicines, rimantadin, amantadine, oseltamivir and zanamivir, were detected. …”
    Get full text
    Article
  19. 1939

    p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways. by Karen S Kelly-Spratt, Kay E Gurley, Yutaka Yasui, Christopher J Kemp

    Published 2004-08-01
    “…This indicates that selection for p53 mutations is a direct result of signaling from the initiating oncogenic lesion, Hras, acting through p19(Arf).…”
    Get full text
    Article
  20. 1940

    PRMT1-methylated MSX1 phase separates to control palate development by Li Meng, Yucheng Jiang, Jiawen You, Yatao Chen, Shuyu Guo, Liming Chen, Junqing Ma

    Published 2025-01-01
    “…Abstract Little is known about the regulation and function of phase separation in craniofacial developmental disorders. MSX1 mutations are associated with human cleft palate, the most common craniofacial birth defect. …”
    Get full text
    Article